Gastrap Gas-related GI complaints

Gastrap® is the NEW development in Gastro-intestinal Health

Intended use for symptomatic treatment of gas-related GI-complaints by : 

  • Favouring gas elimination
  • Improving stool consistency 
  • Restoring healthy flora

Gastrap® is available in chewable tablets



Gastrap® is uniquely  combines two actives : KiOtransine® & Simethicone and peppermint

The combination of KiOtransine® and Simethicone (GASTRAP®) exhibits (1):

  • a defoaming activity, 
  • a water binding capacity
  • a beneficial effect on intestinal microbiota activity.

Would you like to know more about the KiOtransine® technology?

(1) In vitro models including the full SHIME or full SHIME derived technology & In vivo studies in animals. 


What we offer

  • A commitment to safety and performance
  • Distribution under the brand name or a private label
  • A finished product on the market in a timeframe of just 4 months
  • As manufacturer, we take full responsibility
  • Construction of the technical file
  • Post market monitoring
  • Systems are in place to ensure traceability


  • What is the recommended dosage and when should I take it?

    3 to 6 chewable tablets a day as the events occur 

  • Can anyone take the product?

    • Contra-indication in case of allergy or intolerance to one of the compounds present in the formulation.
    • Babies, infants and children should not use GASTRAP®.
    • Due to the presence of sorbitol, subjects suffering from fructose intolerance should not use GASTRAP®.
    • Subjects should ask systematically their doctor or pharmacist about concomitant treatments in order to avoid potential interactions between GASTRAP® and their medicines.
    • Adolescents should use the product only after consulting a doctor.
    • Pregnant or breastfeeding women should use the product only after consulting a doctor.
  • What are the packagings available?

    • GASTRAP® is available in boxes of 20, 30 or 40 chewable tablets